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ABSTRACT

Relationship Between CAG Repeats of theN Terminal Region
of the Androgen Receptor and Body Shape

by

Michael John Wen, Master of Science
Utah State University, 2001

Major Professor: Dr. Deborah R. Gustafson
Departt?ent: Nutrition and Food Sciences

Androgen receptor (AR) gene CAG polymorphisms may be associated with body
shape, and are associated with certain breast and prostate cancers. In addition, body
shape is associated with risk for a variety of diseases, including heart disease, diabetes, and
certain forms of cancer. The CAG repeat in exon l of the AR gene was quantified using
Perkin Elmer Applied Biosystems GeneScan analysis software in 96 and 59 healthy
Caucasian men and women, respectively, who were over the age of 50 years. All
participants had body measurements taken and donated a blood sample. Waist
measurements included circumferences at the 1) umbilicus (wstumb), 2) top ofthe iliac
crest (wstiii), and 3) midpoint between the lowest rib and the iliac crest (wstwst). Waisthip ratio (Wl-IR) was calculated using each corresponding waist measurement,
respectively (WHRUMB, WHRILI, WHRWST). Mean repeat length was significantly

IV

different (p<O.Ol) between men (22 ± 0.3 repeats) and women (23 ± 0.3 repeats) . There
was a significant relationship (p<0.05) between mean individual CAG repeat number and
tertile ofWHRUMB in women based on the mean number ofCAG repeats for each
woman. Waist measurements in women were significantly different for all pairwise
comparisons (p<0.05). In addition, the three measurements ofWHR in women,
WHRUMB, WHRILI, and WHRWST, were significantly different from each other
(p<0.05). Thus, lesser numbers ofCAG repeats may indicate a more androgenic
phenotype in women.

(54 pages)
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CHAPTER I
INTRODUCTION

Due to the modernization of the industrialized nations within the past hundred
years, mortality from infectious diseases has steadily declined. In comparison to
developing countries, industrialized nations have adequate food, health services, and
hygienic education. As a result, decreased mortality, increased longevity, plentiful food,
and a decline in physical activity have given rise to a new epidemic, that of chronic
diseases. Cardiovascular diseases and cancers are now the leading causes of death in the
United States (1). While nutrition and environmental factors, such as smoking and
exercise, undoubtedly play an important role in the causation of these diseases, there exist
potential genetic risk factors that may predispose individuals to chronic diseases.
Epidemiology involves the examination of disease distributions in populations and
the factors that influence these distributions. By examining these distributions and
influencing factors, scientists can better formulate policy for disease prevention in public
health and clinical settings (2). Gordis outlines five steps in examining disease distribution
in a population. First, the possible causes of the disease must be identified, including risk
factors for the disease. This aids in determining what the disease is, and perhaps begins
the process of identifying how the disease can be prevented or cured. Second, the
prevalence of the disease must be determined . This identifies the seriousness and potential
threat of the disease. Is the disease simply endemic or is it more threatening? Third, the
biology of the disease must be studied. History, lethality, and symptoms further aid in
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identifying and defining the disease. Fourth, there must be a health care system that can
provide the clinical care and preventative measures to patients. Finally, epidemiologists
must then establish the basis for public health policy and clinical practices to prevent or
treat the disease (2) .
The major goal of epidemiology is to prevent disease, or to identify populations
that are at high risk for the disease. The ultimate goal is primary prevention, or preventing
a disease from occurring. If that is not possible, then reasonable secondary prevention
must be implemented to identifY and treat the disease (2).
Epidemiology can be further categorized into different fields of study, such as
nutritional epidemiology. The traditional goal of nutritional epidemiology is to examine
nutritional interactions with disease state. As Willett observes, nutritional epidemiology
has been practiced for many years. For example, the observation made by James Lind in
1753 that scurvy could be treated by fresh fruits and vegetables was perhaps one of the
first nutritional epidemiological studies (3) . Over time, nutritional epidemiologists were
able to identify other deficiency diseases, including rickets, beri-beri, and pellagra. In
modem times, nutritional epidemiology is being used to examine the relationship between
diet and diet-related factors, such as body mass index or waist-hip ratio with chronic
disease, such as stroke, heart disease, and cancer. However, due to the multifactorial
etiology of these chronic disease states, as a result of person-to-person variations in
genetics, lifestyle, and diet, other avenues must be explored.
In recent years, molecular epidemiology has emerged as another field of study. A
combination of molecular biology and epidemiology, molecular epidemiology incorporates
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biomarkers to study disease distribution and risk factors (4). This field utilizes the
laboratory methodology of a molecular biologist to study the influence of genetics on
disease. These potential biomarkers can then be used to indicate or identify risk factors
for disease, such that precautions can be taken to prevent onset or slow the progression of
diseases. Potential biomarkers include internal macromolecules, "effect" markers or
biological damage caused by a disease, or genetic susceptibility factors (4). The
importance of molecular epidemiology is growing as a field. Utilizing the power of
molecular biology, researchers can now investigate biomarkers in epidemiological studies
that address the biology of chronic disease. One potential genetic biomarker is the
androgen receptor gene. The androgen receptor may be involved in determining body
shape. This project will attempt to further examine the biology of obesity by studying the
relationship between genetic polymorphism and anthropometry.
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CHAPTER II
LITERATURE REVIEW

Waist-hip ratio
One possible phenotype that may be affected by androgens is waist-hip ratio
(WHR). WHR is used to characterize body shape or body fat distribution. The pattern of

WHR is different between men and women, perhaps due to differences in sex hormones.
Women tend to distribute their weight in their hips (gynoid obesity), creating a pear-like
body shape. This results in a WHR ofless than 1.0. Men, however, tend to distribute
their w~ight around the abdominal region (android obesity), creating an apple-like body
shape. This may lead to a WHR of greater than 1.0. Thus, WHR has been used as a
measurement of central adiposity.
The validity ofWHR measure in assessing actual adipose stores has been
addressed . Heiss et al. noted that dual energy x-ray absorptiometry, computed
tomography, and magnetic resonance imaging were more accurate in estimating abdominal
adiposity, since WHR measurements may underestimate abdominal adiposity in individuals
with both large waists and large hips (5). Goodman-Gruen et al. also observed that waist
circumference was correlated stronger with measurements obtained from bioelectric
impedance and dual energy x-ray absorptiometry than WHR (6). However, these
alternative methods are not appropriate for large, population-based surveys. They are
expensive, not always available, and some expose the test individuals to abnormal amounts
of radiation (5). Moreover, since WHR was correlated with dual energy x-ray
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absorptiometry, using WHR as a measure of central adiposity is valid (5, 6). In a recent
review, Vanltallie states that waist measurements are better at predicting risks for
cardiovascular disease and diabetes than body mass index. Additionally, for
epidemiological studies that involve large numbers of study subjects, waist measurements
are easy to perform, reflect total and abdominal fat accumulation, and are not severely
affected by height (7).
In epidemiological studies, WHR has been correlated with a number of chronic
diseases, including cardiovascular disease, osteoporosis, cancer, and obesity (5, 6, 8, 9).
In relation to cardiovascular disease, Rimm et al. studied 29, 122 men between the ages of
40 and 75 from the Health Professionals Follow-up Study in 1986. They found that both
body mass index and WHR were good risk indicators of coronary heart disease in men (8) .
Men with a WHR greater than 0.98 had a relative risk of 2.76 (95% confidence interval
1.22-6.23) compared to men with a WHR between 0.70 and 0.89. Interestingly, the group
also noted that some measurements of adiposity were better than others at predicting risk
for coronary heart disease, depending on the age-group . Body mass index proved to be a
better indicator for risk than WHR in men younger than 65 years. Conversely, WHR was
a better indicator than body mass index for risk in men older than 65 years of age (8).
In relation to osteoporosis, Heiss et al. found that Caucasian women with a WHR
greater than 0.85, or an android phenotype, tended to have higher bone mineral densities,
as measured by dual energy x-ray absorptiometry, compared to women with a WHR less
than 0.8 5. This was statistically significant for all bone mineral density measurements --
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total body, lumbar spine, femoral neck, Ward's area (the area oflowest bone mineral
density in the femur), trochanter, arm, and leg.
Sellers et al. analyzed data from the Iowa Women's Health Study, a cohort of
41 ,837 women between the ages of 55 and 69 as of 1985, and found that high WHR was
associated with a significant increase in breast cancer risk in women with a family history
of cancer (9). Within the 5-year follow-up, 620 women were diagnosed with breast
cancer. Women with a WHR of greater than 0.906 and a family history of breast cancer
had a 2.1-fold (95% confidence interval 1.43-3 .09) increased chance of developing breast
cancer compared to similar women without a family history ofbreast cancer. Women with
a family history of both breast and ovarian cancer, combined with a WHR of greater than
0.906, had a relative risk of4.8 (95% confidence interval1.55-15 .1) (9).
WHR is also a measure of obesity, which is a known risk factor for cardiovascular
disease, diabetes, and certain cancers. Obesity has become an increasingly important issue
within the past decade, especially in the United States. According to Solomon and
Manson, in a recent 1997 review ofliterature, over one-third of Americans were estimated
to be overweight or obese as of 1991 (1 0). Citing tables generated by the Metropolitan
Life Insurance Company, overweight individuals were defined as being 110-120% over
their ideal body weight. This corresponded to a body mass index (BMI) of24-27.8 kg/m 2
for men and 23-27.3 kg/m2 for women. Obese individuals were defined as being 120180% over ideal body weight, corresponding to a BMI of27.8-40.0 kg/m2 for men and
27.3-40.0 kg/m 2 for women. Individuals with greater values were defined as clinically
obese. In layman's terms, an individual with a BMI of30 kg/m 2 and who was 70
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inches tall ( 5' 10") would weigh close to 165 pounds. Although BMI does not account for
muscle mass or body frame and build, it is correlated with obesity. Citing previous works,
Solomon and Manson defined the term "obesity" as having a WHR of greater than 0.95
for men or greater than 0.8 for women.
A common confounder in studies of chronic disease and body shape in women is
hormone replacement therapy (HRT). Previous investigators had observed that HRT in
women caused differing levels of androgens compared to those women who were not
taking them (5). Heiss et al. noted that women who were not on HRT tended to have
more androgenic hormone levels, and lower estradiol, free estradiol, and sex hormone
binding globulin. While the group stressed that the interaction of hormone replacement
and fat distribution had yet to be explained completely, women on hormone replacement
tended to have lower WHR. This may have been due to the hormones preventing a shift
ofbody fat towards the central body (5).
Therefore, if the androgen receptor gene affects WHR, it may be important in
modifying disease risk as well . This hypothesis may be well founded given other examples
of gene and body phenotype interaction. Although no definitive genes have been
identified which influence body shape, multiple genes are currently being studied to
examine their influence on fat distribution, growth, and other anthropometric variables.
Many of these studies are still inconclusive. Other studies have shown nonsignificant
results when examining individual target genes.
Recently, Hegele et al. noted a significant correlation (P<0.05) between a gene
mutation on chromosome one with a variation in WHR in an isolated population of
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Hutterite men in Canada (11). Hegele et al. found that individuals had one oftwo
prominent genotypes - a normal protein coding for threonine at codon 174 of
chromosome one or a mutant protein coding for methionine at the same position.
Individuals with a homozygous genotype (normal/normal) had larger waist-hip ratios than
those with the heterozygous mutant, suggesting perhaps a protective effect due to the
heterozygosity.
Another example is a missense mutation of the beta-3-adrenergic receptor gene. A
disruption of the genetic code at codon 64 ofthe beta-3-adrenergic receptor leads to the
substitution of arginine for tryptophan. This is referred to as the Trp64 Arg polymorphism.
Initial studies reported an association of the Trp64 Arg polymorphism with increased body
weight, type-2 diabetes, and insulin resistance. However, subsequent investigations were
not consistent with those findings. This led Fugisawa et al. to perform a meta-analysis on
the combined pool of over 9000 individuals studied from 1995 to 1997. When data were
consolidated from 3 1 different studies and 48 different target groups of mixed ethnicity
and gender, it was observed that individuals with the tryptophan to arginine mutation had
an average increase in body mass index of0.30 kg/m2 . Although results seemed to
suggest that such a genetic abnormality might be a factor in weight distribution, it should
be noted that the difference in body mass index is not large. Also, Fugisawa et al .
conceded that the available data may be skewed due to the lack of reported negative
findings (12).
These studies suggest that the mechanisms involved in body weight regulation and
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anthropometry are complicated. The puzzle of obesity and body shape in relationship to
chronic disease risk probably consists of several factors both environmental and genetic.
Hence, to solve the puzzle, it is necessary to identify as many contributing factors as
possible. One such factor may be the androgen receptor.

Androgen receptor gene
The androgen receptor is a member of the steroid hormone receptor superfamily.
It plays an integral role in the regulation of the transcription of genes encoding for sex
differentiation phenotypes. The proposed mechanism of action of the androgen receptor is
as foll<?ws . Androgens in the blood, such as dihydrotestosterone, diffuse through the
plasma membrane of cells and perhaps the nuclear membrane as well. They then bind to
the androgen receptor, which may be located at the surface or within the perinuclear
region of the nuclear membrane. Once bound, the hormone-receptor complex may
undergo a number of reactions, including a conformational change, phosphorylation, and
hetero- or homodimerization. The complex is then transported to the nucleus via a
nuclear targeting signal. The DNA binding region of the receptor binds to specific DNA
promotor sequences to initiate enhanced transcription of sex differentiation genes, which
then affect phenotypes (13) .
The androgen receptor gene is located on the X chromosome. It is comprised of
three ex on regions. The amino terminal region of the protein contains three polymorphic
trinucleotide repeats encoding for repetitive glutamine (CAG), glycine (GGN), and proline
(CCN). A few studies have examined the relationship between the androgen receptor
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polymorphic repeat lengths and disease risk. Most studies on androgen receptor gene
polymorphisms have focused on CAG repeats, since they seem to show the most variation
in quantity. The number ofCAG repeats ranges from 5 to 30 in a normal population.
Some work has also been done examining GGN repeats (14). Little work has been done
with the polyproline region, probably due to its small variable size, which on average is
eight repeats.
Functionality tests have shown that an intact amino terminal region is necessary for
proper transport of the protein into the nucleus, although the exact mechanisms are not yet
known (15 , 16, 17). These experiments characterized the androgen receptor protein and
its functions within the cell.
By performing truncation and deletion experiments, Simental et al. were able to
identify the specific regions of the androgen receptor that were essential. Utilizing
restriction endonucleases and site specific mutagenesis via the polymerase chain reaction,
the group created mutant plasmid vectors which were then transfected into cells and
studied for activity (15). The first segment ofthe experiment examined deletions to the
four major elements of the androgen receptor. These were the amino terminal region, the
DNA binding region, the nuclear translocation signal, and the hormone binding region.
Subsequent transcription levels were measured to determine localization and nuclear
activity. Deletion of the DNA binding region eliminated all transcriptional activity.
Deletion of the hormone binding region, in addition to the DNA binding region, also
resulted in nondetectable levels of transcription. However, mutants, which contained an
intact amino terminal region, DNA binding region, and nuclear translocation signal, but
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not the hormone binding region, still exhibited transcriptional activity at approximately
l 0% percent of wild-type vectors. This suggested that the mutant receptor was

constitutively active, and that the amino terminal region might be necessary for promotor
activity. Deletion of the nuclear translocation signal alone still resulted in transcriptional
activity equal to that ofwild-type. However, the majority of mutant receptor complexes
were located in the cytoplasm. This indicated that the nuclear translocation signal
facilitated transport of the receptor to the nucleus, but was not essential for gene
transcription. This was because the decreased number of receptor complexes were able to
passively translocate to the nucleus to activate transcription at levels similar to wild-type.
The second segment of the experiment examined the role of the amino terminal
region of the androgen receptor. Stepwise truncation of the amino terminus located a
region within amino acids 141-338 essential for transcriptional activity. This region did
not include the polyglutamine nor the polyglycine repeat regions (17, 18). This result
coincided with other studies of steroid receptors (15). Simental et al. therefore concluded
that it was very possible that this region of the androgen receptor protein contained
sequences which controlled transcriptional activity. However, they also noted that
deletion of these sites could have caused conformational changes to the protein, which
could have been responsible for the lack of transcription.
While Simental et al. noted the importance of the amino terminal region as a
whole, Chamberlain et al. focused primarily on the effects of artificially expanding the
CAG repeat region. Utilizing restriction endonucleases, Chamberlain et al. created
deletion mutant rat and human androgen receptors which completely lacked the CAG
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repeat region. The deletion of the CAG repeats caused a significant increase in
transcriptional activity (P<0.002 for the rat mutant, and P<0.02 for the human mutant).
Therefore, it was concluded that the polyglutamine repeats encoded by the CAG repeat
region served to inhibit normal transcriptional activation in the androgen receptor (16).
Next, the group examined the effect of increasing the number of CAG repeats. The CAG
repeat region was first isolated from wild-type DNA and then transformed into plasmids to
create mutants with 25, 35, 49, and 77 CAG repeats. The DNA was then transfected into
cells to create mutant receptors. A stepwise decrease in the level of transcriptional
activity was observed with each increase in CAG repeat size. Repeat sizes of 49 and 77
were significantly different (P<0.02 and P<0.001 , respectively) from wild-type receptors.
This study illustrated that a lesser number of CAG repeats in vitro increased overall gene
transcription, while genetically engineered longer repeats caused a decrease in
transcriptional activity (16). This does well to enforce the importance of the CAG repeat
regiOn.
The question has been raised, therefore, as to the relationship between the
androgen receptor CAG repeat length to human chronic diseases. Perhaps the most
interesting data linking androgen receptor CAG repeat number to disease risk are those
recently reported on prostate cancer. It has been noted that race is a risk factor for
prostate cancer ( 12, 19, 20). African American men are at a 30 times increased risk for
prostate cancer compared to Japanese and Chinese men who live in their native country.
African American men also have 60-70% higher rates of prostate cancer compared to nonHispanic white Americans (19). Ross et al. also noted that there are no immediate
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increases in prostate cancer rates among Asians who immigrate to the United States.
Rather, a slight increase is observed over a longer period oftime, possibly stretching for
generations. These data suggest that, unlike colon cancer, diet might have less of an effect
on prostate cancer risk (19). In contrast, hormone levels might have a larger effect since
the prostate is a hormone-dependent tissue. It has been well established that Asian men
tend to have lower free testosterone levels, and may, as a result, experience less prostate
cancer (21 ). Conversely, African American men have higher levels of free testosterone
and a higher incidence of prostate cancer (21, 22). Based on this observation, Irvine et al.
investigated CAG repeat number in a population of African Americans, non-Hispanic
white Caucasians, and Asians in Los Angeles County. Similar ethnic differences in
prostate cancer incidence were observed in this study as observed in the rest of the world.
African Americans had the highest incidence of prostate cancer (116 per 100,000 personyears) compared to that of non-Hispanic white Americans (71 per 100,000 person-years)
and Asian (Japanese and Chinese) Americans (28 per 100,000 person-years) (14).
Irvine et al. also estimated relative risk in relation to the number of CAG repeat
number. Irvine et al. chose to use the median number of CAG repeats observed among
Asian men, the ethnic group with lowest prostate cancer risk, as the comparison group.
Thus, men with fewer than 22 CAG repeats were compared to men with greater than or
equal to 22 CAG repeats. African Americans tended to have the highest percentage
(75%) of participants with CAG repeats less than the average of22, when compared to
non-Hispanic white Caucasians (62%) and Asians (49%) (14). Thus, the CAG repeat
profile matched their disease risk profile.
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The investigators then examined the GGN repeat region. Seventy percent of Asian
men had 16 GGN repeats. Due to the high prevalence of 16 GGN repeats among the
lowest risk group, risk was assessed among those with 16 repeats versus not having 16
repeats. Fifty-seven percent of non-Hispanic white Caucasian men had this number of
repeats, while only 20% of the African American men had 16 GGN repeats. Although the
functionality of this region is unknown, longer repeats were prevalent among Asians
compared to African Americans and non-Hispanic white Caucasians, who were at high
and intermediate risk for prostate cancer, respectively. When combining the two allele
groups, less than 22 CAG repeats and not 16 GGN repeats, a nonsignificant (P<0.08) 2.1fold increased risk for cancer was observed (14). This finding was confirmed in a later
similar study by Stanford et al. (23).
Knowing that the length of the amino terminus influences the regulation of gene
transcription, one can see how the variable number of repeats may influence risk for
prostate cancer. A probable hypothesis is that the longer repeats observed in Asian men
are associated with decreased transcription, such that fewer protein products, i.e.,
receptors, are created. This leads to decreased cell differentiation, thereby lowering the
risk for cancer (22, 24). The scenario for African American men, would be the opposite.
Another study linked CAG repeat length with age of prostate cancer onset. Hardy
et al. studied a group of 109 men (95% Caucasian) with confirmed prostate cancer. A
significantiy positive association (P<0.05) between age at cancer onset and longer CAG
repeat lengths was observed (21 ). In addition, nonsignificant associations were observed
between length of the CAG repeat region and the aggressiveness of the cancer. Based on
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prostate specific antigen tests and response to hormonal treatment, it was noted that men
with longer CAG repeats tended to have less aggressive cancers that were more
responsive to treatment (21). These results would indeed suggest the possibility ofusing
the androgen receptor CAG repeat genotype as a marker for prostate cancer.
Giovannucci et al. utilized a case-control study from a cohort of men who were
part of the Physician's Heath Study to examine the relationship between CAG repeats and
prostate cancer risk. The study consisted of 14,916 predominantly Caucasian physicians,
who donated blood samples and completed questionnaires over a 13-year period. They
identified 591 prostate cancer cases, which were confirmed through the examination of
medical records. Each case was matched to a control, based on age and smoking status.
Cases were ranked according to severity or stage of prostate cancer, and cases and
controls were placed into categories based on number of CAG repeats. The categories
were greater or equal to 26, 25 and 24, 23 and 22, 21, 20, 19, and less than or equal to
18, based on "relatively equal numbers" of participants in each repeat category (22).
When comparing all cases to controls with repeats less than or equal to 18 to those men
· with repeats greater than or equal to 26, significantly increased prostate cancer risk was
observed (relative risk = 2.23, confidence interval = 1.08 - 4.61, P for trend = 0.002).
Additionally, a similar risk was found when comparing cases with high grade or advanced
stage prostate cancer to controls, again with the extreme CAG repeats (relative risk=
1.89, confidence interval= 0.96-3 .75, P for trend= 0.007). The authors only observed
significant results when comparing the extreme categories, although relative risk did
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increase with each decrease in CAG repeat category (22). These data showed that not
only was there a positive association between CAG repeat number and risk of prostate
cancer, but confirmed that men with fewer CAG repeats were at a greater risk for having a
higher grade or more fatal prostate cancer (22).
While the implications of CAG repeats and prostate cancer are fascinating, it has
only been within the past few years that scientists have tried to draw correlations between
CAG repeats and diseases prominent in women, such as breast cancer.
One of the most difficult issues in analyzing the CAG repeats obtained from
women is X chromosome inactivation. To protect the body from a "double dose" of
genetic products, female cells randomly inactivate one of their two X chromosomes. It is
believed that this occurs in each cell quite early in life during embryonic development. In a
developed female, there is a mixture of cells equally containing both inactivated paternal
or maternal X chromosomes. It has been observed, however, that groups of cells
containing either the paternal or maternal X chromosome tend to congregate together in
small clusters. This probably results when daughter cells replicate from the original
embryonic mother cell (25).
The exact biological pathways of X chromosome inactivation are yet unclear.
Also, it is not known how the cell decides which of the two chromosomes to inactivate. It
has been observed that the inactivated chromosome is more condensed and is highly
methylated. This methylation prevents transcription factors from initiating gene
transcription. It is also believed that whichever X chromosome is inactivated remains so
permanently. The only exception to this rule are germ cells (25).
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Since any given tissue has a mixture of cells, it is not possible to determine which
of the two X chromosomes in women may be influencing phenotypes. It may be the
paternal chromosome, the maternal chromosome, or more likely both of the
chromosomes. Careful consideration, therefore, must be taken when determining how to
analyze CAG repeat data from women in terms of predicting disease risk or phenotypic
expression.
Although there are methods which can identify the inactivated X chromosome,
these methods would only be beneficial in determining risk for a disease, such as cancer,
because most cancers are believed to originate from one cell. Interestingly, in cancer, it
has been observed that tumors have the same inactivated X chromosome, suggesting that
cancer cells are indeed derived from one original carcinogenic cell. This observation was
noted by examining X-linked marker genes in both malignant and benign tumors (25).
Allen et al. developed a protocol for digesting genomic DNA with methylation sensitive
endonucleases prior to amplification by the polymerase chain reaction. With this method,
the active X chromosome was digested, and only the inactive X chromosome was
amplified (26). Again, however, this protocol would only be helpful in identifying the
active X chromosome in tumors. Further genetic analysis would need to be performed to
determine the CAG repeat lengths in both X chromosomes. However, by using combined
protocols, researchers have much greater power in examining breast cancer risk.
The proposed relationship between androgen receptor CAG repeat number and
breast cancer in women is different from prostate cancer in men. This is logical, due to the
different biology ofbreast cancer itself In prostate cancer, elevated testosterone levels
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are thought to contribute to disease risk. A form of testosterone binds to the androgen
receptor to activate downstream phenotypes. In breast cancer, elevated estrogen levels
are thought to contribute to disease risk by binding to the estrogen receptor to affect
downstream phenotypes. In women, the androgen receptor plays an uncertain role in
breast cancer risk. It is hypothesized that the androgen receptor may play a role in breast
tumor growth and progression. Since androgens have been shown to inhibit the growth of
some breast cancer cell lines, a more transcriptionally active androgen receptor may be
beneficial to women in relation to breast cancer. Therefore, an androgen receptor with
shorter CAG repeats may decrease the risk of breast cancer in women (27). Examination
of this hypothesis, however, has just been initiated within the past few years, and results
are conflicting.
The inherited BRCA-1 gene mutation is associated with a greatly increased risk for
breast cancer. However, within this subset of high risk women, there is still a great deal of
variation in breast cancer incidence and progression. Therefore, Rebbeck et al . initiated a
study to examine other potential genes that might increase risk in 304 women with a
BRCA-1 mutation. The hypothesis was that other genes, particularly those involved in
hormone signaling, might interact with the BRCA-1 mutation to modify breast cancer risk
(27).
The results of this study showed that women who inherited the BRCA-1 mutation
and carried at least one allele with greater than or equal to 28 CAG repeats were at a
significantly increased risk for breast cancer. Analysis of CAG repeat data was conducted
in three steps. First, risk for breast cancer was assessed if at least one of the alleles was
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short. Second, risk was estimated based on having at least one "very long allele," greater
than or equal to 28 CAG repeats (27). Finally, overall risk was examined by taking the
mean number of repeats based on both alleles from one individual and considering it as a
single value. The results showed that women with at least one allele greater than or equal
to 28 CAG repeats had a hazard ratio of 1.81 (95% confidence interval1.06-3.08).
Therefore, Rebbeck et al. concluded that their initial hypothesis was potentially valid, and
that having at least one long allele somehow contributed to increasing breast cancer risk
by modifying hormonal pathways in women with the BRCA-1 mutation. For example, a
longer gene could result in the production of a less transcriptionally active androgen
receptor, which would lead to increased breast cell proliferation due to the absence of
androgen-induced cell signals and transcripts. Another possibility would be that an altered
androgen receptor affects other hormones, and perhaps modifies circulating levels or
bioavailability of estradiol in mammary tissue (27).
In contrast, Spurdle et al. found no significant associations between CAG repeat
length and breast cancer in a case-control study of Australian women. However, it should
be noted that this study focused specifically on early onset female breast cancer in women
less than 40 years. Spurdle et al . examined 368 cases and 284 controls and measured
CAG repeats. Alleles were classified as being long or short using the value of 22 repeats,
the approximate median value. A number of statistical methods were used to examine the
relationship between CAG repeats and breast cancer risk. First, women were assigned to
one of three categories. These categories were zero, one, or two depending on whether
the woman had no, one, or two alleles greater or equal to 22 CAG repeats, respectively.
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Next, all alleles were analyzed to test the linear effect of greater or equal to 22 CAG
repeats on risk ofbreast cancer. Each woman, therefore, contributed two alleles, and
related data were doubled. For the third analysis, risk was assessed if a subject had at
least one of the two alleles greater than or equal to 22 CAG repeats. Next, the group then
averaged the two CAG repeats of an individual woman and used the mean value of each
woman to examine risk. Finally, risk was assessed by examining the effects of each
increase of CAG repeat number. This particular study points to the complexity of
analyzing these data, since there is no standard method of analysis. In all calculations, the
group was unable to identify any significant association between CAG repeat number and
breast cancer risk in women under the age of 40 years. Despite their negative findings, the
group noted that they did not examine gene-gene interactions or gene-environment
interactions (28).
Overall, there has been little work done in examining the relationships among CAG
repeat number and phenotypes. To date, there has only been one study that has correlated
CAG repeats with WHR. Unfortunately, this was done in a small, atypical population,
that of hirsute Hispanic women. Androgen excess in women is often characterized by
hirsutism, acne, android obesity, increased WHR, and male pattern baldness. Also,
androgen excess in women has been correlated with increased risk for cardiovascular
disease (29, 30). Legro et al. examined a population of 110 female Hispanics with various
infertility problems, including tubal ligation, ovulation disorders due mostiy to polycystic
ovary syndrome, or male factor infertility. The majority of the women were
hyperandrogenic and hirsute, signifying an abnormal study population both
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endocrinologically and, perhaps, genetically. CAG repeat number was determined by
interpolating allele size from a standard curve, which was derived from a molecular weight
size marker run on an agarose gel. While the scientists claim that this method was
reproducible, they also conceded that it was not as accurate as denatured polyacrylamide
gel electrophoresis. Statistically, all women contributed two alleles which were
considered individually and correlated with body shape variables. A positive correlation
was observed between CAG repeat number and WHR (r=0.39, P=0.028), suggesting an
increase in receptor activity with an increase in CAG repeat number (31 ). This finding
was in contrast to studies on prostate cancer, as well as with in vitro experiments, which
suggest that longer repeat length would lead to decreased receptor activity.
Other studies focusing on androgen receptor gene length have been conducted
among those with genetic diseases, such as those with Kennedy' s disease. Kennedy' s
disease was first characterized in 1968 as one which caused muscle weakness and
degradation (32). These individuals exhibit almost complete testosterone insensitivity. La
Spada and his research group were the first to identify a possible genetic mutation as a
cause of the disease (33). When patient genotypes were examined, it was observed that
these individuals possessed 20 to 30 more CAG repeats than the average person.
Subsequent studies by other researchers confirmed these findings, as well as further
characterized the nature of the disease. MacLean et al. recently examined phenotypic
differences caused by the amount of CAG repeats in fibroblast cells collected from a small
population of individuals affected by Kennedy's disease (34). When compared to
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controls, binding affinity assays revealed decreased affinity of the mutated androgen
receptor to synthetic androgens in these individuals. This confirmed that the increased
number of glutamine residues in the receptor was adversely affecting hormone binding.
Although the results correlating CAG repeat number to other phenotypic attributes, such
as testicular atrophy and gynecomastia, were not statistically significant, a trend of
increased CAG repeat number with decreased age of onset of symptoms was noted.
Therefore, men with an abnormally greater number of repeats were even more insensitive
to androgens, and therefore were more affected than individuals with a lesser number of
repeats. While these studies confirmed a potential functional manifestation of the repeats,
it did little to suggest the possible outcomes of less dramatic variations in repeat number in
a healthy, genetically "normal" human population.
It is our hypothesis that CAG repeat number of the androgen receptor gene will be
associated with body shape variables in a healthy population of Caucasian men and women
over the age of 50 years. Information gathered in this pilot study may lead to further
expansion of our hypothesis to other races, ages, and phenotypes, in the hope to create a
convenient biomarker with which we can predict risks of cardiovascular disease, diabetes,
and cancer.
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CHAPTER III
METHODS

Study population
One hundred fifty-five healthy Caucasian participants over 50 years of age, 96 men
and 59 women, were enrolled in a cross-sectional study to assess the relationship between
androgen receptor CAG repeat genotype and body shape. Participants were selected from
a volunteer pool of the local Cache County and greater Utah and Arizona regions.
Participants were screened to determine eligibility using a telephone questionnaire.
Eligibili.t y was based on criteria that did not interfere with the study hypothesis . Relevant
to these analyses, participants with a BMI greater than 36 kg/m 2, smokers, alcohol
drinkers (more than five drinks per week), users of cholesterol-lowering medications and
hormone replacement therapies, and previous histories of disease were not eligible to
participate in the study. Women must have been at least one year post menopausal, based
on the date of their last menstrual period.

Data collection
Eligible participants were asked to make a single visit to the Nutrition and Food
Sciences building at Utah State University or to a Quest Diagnostics Clinic in the Salt
Lake City or St. George, Utah, areas to complete the study. Participants provided written
consent according to guidelines of the Utah State Institutional Review Board before
engaging in the study protocol.
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During the study visit, participants were required to provide a blood sample, had
body measurements taken, and completed diet and lifestyle questionnaires. Participants
arrived in the morning having fasted for 12 hours with nothing to eat or drink except
water and/or medications.
Body measurements included weight, height, waist circumferences, and hip
circumference. Participants were asked to undress to their undergarments and put on a
hospital gown to minimize bias due to thickness of clothes. Weight and height
measurements were done according to reported procedures (35). Weight was measured
to the nearest quarter pound, and height was measured to the nearest quarter inch.
Measurements were duplicated to ensure accuracy. Waist measurements included
circumferences at the umbilicus (wstumb), at the top ofthe iliac crest (wstili), and
midpoint between the lowest rib and the iliac crest (wstwst). The hip measurement was
taken at the greatest diameter of the gluteal muscles. Waist and hip measurements were
taken to the nearest half centimeter. All measurements were taken at least twice. If there
was a difference greater than 0.5 em, a third measurement was taken until agreement was
within 0. 5 em. This was particularly important when measuring circumferences on
women, since experience revealed that identifying body hallmarks on women, particularly
among overweight women, was quite difficult.
Participants were required to donate enough whole blood for DNA extractionapproximately 12-16 milliliters. A certified phlebotomist collected 8-milliliter blood
samples into vacutainer blood collection tubes containing an acid-citrate dextrose solution
for DNA. Two milliliters of serum collected in a SST vacutainer tube was used for blood
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lipid analysis, which included total cholesterol, total triglycerides, HDL and LDL, as an
incentive for participation.
Blood for DNA extraction was processed within 2 days of the draw. Blood drawn
for lipid determination was processed immediately and serum was stored at
-20 degrees Celsius. Extraction followed standard protocol (36). Briefly, blood samples
were transferred into 50-milliliter conical tubes. A hypertonic lysis solution was used to
lyse red blood cells. White blood cells were then pelleted and lysed in a sodium dodecyl
sulfate solution overnight at 37 degrees Celsius. RNAse and proteinase K were added to
degrade RNA and proteins, respectively. Proteins were precipitated in a 7.5M ammonium
acetate solution and discarded. DNA was precipitated using absolute ethanol and allowed
to precipitate overnight at room temperature to attain maximum yield. The ethanol was
aspirated and the pellet was allowed to air dry. Three milliliters ofTris-EDTA was used
to resuspend the pellet, and the final solution containing the DNA was aliquoted into three
eppendorftubes for long-term storage at 4 degrees Celsius. Prior experience had shown
no depreciative degradation for storage of the DNA at this temperature.

Genotyping
Approximately 5 microliters of DNA solution was used in polymerase chain
reactions (PCR) to determine the number of CAG repeats in the androgen receptor gene.
Flanking primers designed from the known sequence of the androgen receptor were
selected and synthesized for amplification ofthe CAG repeat region (12). The 5'
oligonucleotide (agt tag ggc tgg gaa ggg tct) was specially labeled with a 6-FAM
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fluorescent tag (Operon Technologies, Incorporated, Alameda, CA) at the 5' end for
quantitative purposes described later. The 5' oligonucleotide and the 3' oligonucleotide
(egg ctg tga agg ttg ctg a) were combined under the following PCR conditions - 96
degrees Celsius, 4 minutes; 96 degrees Celsius, 1 minute; 57 degrees Celsius, 45 seconds;
72 degrees Celsius, 1 minute; 35 cycles; 72 degrees Celsius, 4 minutes; held at 4 degrees
Celsius. Ten microliters ofPCR product was loaded on an agarose gel and viewed for
quality and relative quantity. Depending on the results, products were further purified to
eliminate extraneous primer dimers, salts, and other contaminants. While this was not
totally necessary and did not affect the results, it facilitated computerized analysis.
Approximately 50 picomoles of labeled PCR products were loaded on a 6%
denaturing polyacrylamide gel and run for 14 hours for Genescan Analysis. Genescan
software (Perkin Elmer Applied Biosystems, Foster City, CA) was used to estimate DNA
fragment size. This was accomplished using a laser to excite the fluorescent tag of the 5'
oligonucleotide. Utilizing an internal lane standard, the analysis software allowed
determination of fragment size, within a base pair. This was done by comparing the
position of the desired band to the internal lane standard. Subtracting the bases flanking
the CAG repeat provided the total number ofbases of the repeat region. This number was
divided by 3 to determine the number of repeats.

Statistical analyses
Three waist-hip ratios were calculated from the measurements. Waist-hip ratio
was calculated using waist measurements taken at the umbilicus (WHRUMB), the iliac
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crest (WHRllJ), and midpoint between the lowest rib and the iliac crest (WHRWST).
Body mass index (BMI) was calculated as kg/m 2
Pearson correlation coefficients were calculated to measure the relationship
between CAG repeat number and anthropometric variables, as well as the relationship
between individual anthropometric variable to each other. Also, t-tests were used to
determine the relationship between <22 versus

~22,

<23 versus ~23, and <24 versus

~24

CAG repeats in relationship to mean anthropometric variables. One-way analysis of
variance (ANOV A) was used to assess relationships between mean CAG repeat number
by tertiles of anthropometric variables. Since women have two alleles at this X-linked
locus, the aforementioned tests were used in two different ways. First, each woman
contributed one set of anthropometric variables per mean CAG repeat number of her two
alleles (n=59). Then, the data were reanalyzed with each woman contributing multiple
sets of anthopometric variables for each allele (n= 118). ANOV A was used to assess
relationships between groups when comparing female participants who were classified into
one of three gene allele categories based on the length of each allele. These categories
were 1) both alleles less than or equal to 23 or 24, 2) one allele was less than or equal to
23 or 24, or 3) both alleles were greater than 23 or 24. SPSS version 7.0 and SigmaStat
version 2.0 were used to analyze study data.
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CHAPTER IV
RESULTS

Characteristics ofthis study population are shown in Table I. The mean age of
women was 70 ± 1.0 years, and the mean age of men was 69 ± 0.9 years . Mean CAG
repeat number was significantly (p<O.Ol) higher in women versus men. The mean number
of CAG repeats in women and men was 23 and 22, respectively. The range of CAG
repeats was 16 to 32 and 11 to 31 in women and men, respectively. Distii.butions are
shown in Figure 1.
.There was a significant relationship (p<O.OS) between CAG repeat number and
tertile ofWI-IR.urvtB in women, when the mean CAG repeat value was used for each
woman. These data are shown in Table 2. However, no significant relationships were
observed for tertiles ofWHRILI, WI-IR.WST, wstumb, wstili, wstwst, hip, or BMI by
mean CAG repeat number in women (Tables 2 and 3). Also, no significant associations
were observed between any anthropometric measurements and mean CAG repeat number
in men. These data are shown in Table 4 .
The median AR repeat number was used to categorize men and women in
relationship to anthropometric variables. There were no significant differences in mean
WI-IR.urvtB, WHRILI, WI-IR.WST, wstumb, wstili, wstwst, BMI, weight, or height in men
who had <22 versus 2::.22 repeats or in women who had <23 versus

~23

repeats (Table 5).

There were no significant differences between groups when comparing female
participants who were classified into one of three genetic allele categories. These
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Table 1 Characteristics of study participants a
Men

Women

n= 96

n= 59

Age

68 .8 ± 0.9

70.2±1 .0

CAG Repeats

22 ± 0.3 b

23 ± 0.3

b

Height (em)

175.44 ± 0.69

161.55 ± 0.92

Weight (kg)

77.85 ± 0.98

64.13 ± 1.36

25.32 ± 0.31

24 .58 ± 0.49

WHRUMB

0.977 ± 0.005

0.897 ± 0.010 c

WHRILI

0.975 ± 0.005

0.956 ± 0.009 c

WHRWST

0.978 ± 0.006

0.852 ± 0.010 c

wstumb (em)

98 .59 ± 0.79

90.06 ± 1.54 c

wstili (em)

98 .35 ± 0.82

95 .94 ± 1.43

c

wstwst (em)

98 .66 ± 0.92

85.43 ± 1.35

c

Hip (em)

100.82 ± 0.55

100.25 ± 1.00

Cholesterol

216.56 ± 3.78

216.63 ± 5.04

BMI (kg/m

2

)

a

Values are mean ± SE

b

P<O.Ol

c

P<0.05 for all pairwise comparisons
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categories were if I) both alleles were less than or equal to 23 or 24, 2) only one allele
was less than or equal to 23 or 24, or 3) both alleles were greater than 23 or 24 (Tables 6
and 7).
No significant relationships were observed in correlation analyses relating CAG
repeat number and anthropometric variables for men or women (Tables 8 and 9).
The three measurements ofWHR in women, WHRUMB, WH.RllJ, and
WHRWST were significantly different from each other (P<O.OS). Waist measurements in
women were also significantly different for all pairwise comparisons (P<O.OS). There is
currently no specific universal protocol for measuring waist circumference.
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Figure 1 Distribution of CAG repeat alleles for men and women

Table 2 Comparison of categorical anthropometric measurements and average CAG repeat number
in women (n=59)

a

CAG
Tertile 1

CAG
Tertile 2

ReEeat

Tertile 3

ReEeat

CAG

p

ReEeat

Value

whrumb

0.723-0.856 23 ± 0.6

0.856-0.925 24 ± 0.6

whrili

0.780-0.936 23 ± 0.6

0.936-0.987 24 ± 0.5

0.987-1.093 24 ± 0.6

0.488

whrwst

0.696-0.818 23 ± 0.7

0.818-0.877 24 ± 0.6

0.877-1.025 22 ± 0.4

0.092

b

0.925-1.104 22 ± 0.4

b

0.034

wstumb (em)

68.5-85.5

23 ± 0.5

85 .5-94.5

23 ± 0.6

94.5-127 .3

24 ± 0.6

0.507

wstili (em)

74.0-90.7

23 ± 0.7

90.7-101.0

24 ± 0.6

101.0-126.0 23 ± 0.5

0.658

wstwst (em)

68.0-80.0

23 ± 0.5

80.0-90.0

23 ± 0.5

90.0-113 .3

24 ± 0.7

0.439

hip (em)

84.5-97.5

24 ± 0.6

97.5-102.0

23 ± 0.6

102.0-121.0 23 ± 0.5

0.401

17.4-23 .1

23 ± 0.5

23 . 1-25 .8

24 ± 0.6

23 ± 0.6

0.598

BMI (kg/m
a

2

)

Values are mean ± SE

b

25 .8-35.4

P<0.05

w

Table 3 Comparison of categorical anthropometric measurements and average CAG repeat number
in women (n=118)

a

CAG
Tertile 1

ReEeat

CAG
Tertile 2

ReEeat

Tertile 3

CAG

p

ReEeat

Value

whrumb

0.723-0.856 23 ± 0.5

0.856-0.925 24 ± 0.5

0.925-1.104 22 ± 0.4

0.063

whrili

0.780-0.936 23 ± 0.5

0.936-0.987 24 ± 0.5

0.987-1 .093 23 ± 0.5

0.623

whrwst

0.696-0.818 24 ± 0.6

0.818-0.877 24 ± 0.5

0.877-1.025 23 ± 0.4

0.072

wstumb (em)

68 .5-85.5

24 ± 0.5

85.5-94.5

23 ± 0.5

94.5-127.3

23 ± 0.5

0.373

wstili (em)

74.0-90.7

23 ± 0.5

90.7-101.0

23 ± 0.5

101.0-126.0 23 ± 0.5

0.665

wstwst (em)

68.0-80.0

24 ± 0.5

80.0-90.0

23 ± 0.5

90_0-113 .3

23 ± 0.5

0.275

hip (em)

84.5-97.5

24 ± 0.6

97.5-102.0

23 ± 0.6

102.0-121.0 23 ± 0.5

0.327

17.4-23.1

23 ± 0.5

23.1-25.8

24 ± 0.6

23 ± 0.5

0.453

BMI (kg/m
a

2

)

25 .8-35.4

Values are mean ± SE

w

N

Table 4 Comparison of categorical anthropometric measurements and average CAG repeat number
in men (n=96)

a

CAG
Tertile 1

ReEeat

CAG
Tertile 2

ReEeat

'fertile 3

CAG

p

ReEeat

Value

whrumb

0.876-0.962 22 ± 0.4

0.962-0.997 22 ± 0.5

0.997-1.064 22 ± 0.7

0.649

whrili

0.875-0.957 22 ± 0.4

0.957-0.992 22 ± 0.4

0.992-1.120 22 ± 0.7

0.812

whrwst

0.838-0.956 23 ± 0.4

0.956-1.001 21 ± 0.5

1.001-1.117 23 ± 0.7

0.193

wstumb (em)

80.1-94.0

22 ± 0.4

94.0-102.6

22 ± 0.6

102.6-120.5 22 ± 0.6

0.930

wstili (em)

80.2-95 .0

22 ± 0.4

95 .0-102.0

22 ± 0.6

102.0-120.3 22 ± 0.6

0.819

wstwst (em)

80.2-95.0

22 ± 0.4

95 .0-102.8

22 ± 0.6

102.8-124.0 22 ± 0.6

0.787

hip (em)

89.4-98 .0

22 ± 0.4

98.0-103 1

21 ± 0.7

103 .1-118.0 23 ± 0.5

0.178

23.68-26.65 23 ± 0.4

26.65-33 .29 22 ± 0.7

0.446

BMI (kg/m
a

2

)

17.65-23.68 22 ± 0.5

Values are mean ± SE

w
w

Table 5 Comparison of anthropometric measurements and categories
of CAG repeat number
Men (n=96)
whrumb
whrili
whrwst
wstumb
wstili
wstwst
BMI

t
-0.555
-0.872
-0.382
-1.042
-0.877
-0.804
-0.277

p

0.58
0.385
0.703
0.3
0.383
0.423
0.782

Women (n= 118)
t
whrumb
0.822
whrili
whrwst
0.598
wstumb
1.521
wstili
0.622
wstwst
1.458
BMI

p

0.413
0.4
0.551
0.131
0.535
0.147
0.472

w

~
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Of particular usefulness in studies involving measurements of WHR are data on
relationships between WHR and other indicators of body size. Of note in this population
are the significant correlations between WHRUMB, WHRILI, WHRWST, wstumb, wstili,
wstwst, and body weight and BMI in both women and men. These data are shown in
Tables 8 and 9.

Table 6 Comparison of mean anthropometic measurements and
categorical CAG length classification of women
CAG Length Category a
0

I

2

p

whrumb

n=IO

n=28

n=21

0.233

whrili

n=lO

n=28

n=21

0.926

whrwst

n=IO

n=28

n=21

0486

wstumb

n=10

n=28

n=21

0.093

wstili

n=IO

n=28

n=21

0.609

wstwst

n=IO

n=28

n=21

0. 152

hip

n= 10

n=28

n=21

0.197

BMI

n=lO

n=28

n=21

0.689

a

0 = both alleles ~ 23, 1 = one allele ~ 23, 0 = both alleles ;:::: 23

w
0\

Table 7 Comparison of mean anthropometic measurements and
categorical CAG length classification of women

CAG Length Category

a

0

1

2

p

whrumb

n=17

n=28

n=l4

0 _353

whrili

n=l7

n=28

n=l4

0.344

whrwst

n=17

n=28

n=l4

0.170

wstumb

n=l7

n=28

n=14

0.107

wstili

n=l7

n=28

n=14

0_163

wstwst

n=17

n=28

n=14

0.053

hip

n=17

n=28

n=l4

0_132

BMl

n=l7

n=28

n=l4

0_102

a

0 =both alleles~ 24, 1 =one allele~ 24, 0 =both alleles:::: 24

w

-...1

Table 8 Pearson correlation coefficients between anthropometric measurements in women

CAG Repeat

weight

BMI

WHRUMB

WHRILI

WHRWST

wstumb

CAG Repeat

1.000

weight

-0 .043

BMI

-0 .035

0.804

WHRUMB

-0 .142

0.441

< -0 .001

0.421

a

0.479 a

0.752

WHRWST

-0 .061

0.307

b

0.395

0.759 a

0.764 a

wstumb

-0 .180

0.805

a

0.766 a

0.835

a

0.623

a

0.569

a

8

0.664

a

0.760 a

0.551

a

0.901

0.727 a

0.679 a

0.784

a

0.888

WHR!LI

a
3

1.000
0.475

-0 .147

0.848

a

0.819

wstwst

-0.098

0.775

a

0.775

P<0 .01

b

wstwst

1.000

wstili

a

wstili

a

a

a

1.000
a

1.000
1.000
1.000
3

a

1.000
0.891

a

1.000

P <O.OS

w
00

Table 9 Pearson correlation coefficients between anthropometric measurements in men

CAG ReEeat

weight

BMI

WHRUMB WHRILI

WHRWST wstumb

wstili

CAGRepeat

1.000

weight

1.000

BMI

0.016

0.787

a

1.000

WHRUMB

0.008

0.395

a

0.563 a

WHRILI

-0.099

0.410a

0.569 a

0.929

WHRWST

-0.162

0.454 a

0.628 a

0.900 a

0.919 a

wstumb

-0.159

0.827 a

0.845 a

0.751 a

0.713 a

0.735

wstili

-0.006

0.822 a

0.843 a

0.730 a

0.776 a

0.764 a

0.974 a

1.000

wstwst

-0.050

0.808 a

0.852 a

0.729 a

0.744 a

0.830 a

0.960 a

0.968 a

wstwst

1.000

1.000
a

1.000
1.000
a

1.000

1.000

a P<0.01

w

\0

40

CHAPTER V
DISCUSSION

This study is the first to suggest a significant relationship between CAG repeat
number and specific measures ofWHR in older Caucasian adult women. Mean CAG
repeat number and distributions were comparable to those observed in other populations
of men and women (14, 22, 27, 28). Since this relationship was observed for only certain
measures ofWHR, and since WHR measurements were significantly different among
women, care must be taken with regard to standardization and interpretation ofWHR
measurements in future studies of body shape and chronic disease risk.
Of particular note is that in women, the highest tertiles of WHRUMB are related
to a fewer number of CAG repeats, and there are significantly fewer CAG repeats in men
versus women. A higher WHR in women has been shown in some studies to be related to
a more androgenic blood sex hormone profile (37, 38, 39). Thus lesser numbers ofCAG
repeats may indicate a more "male" phenotype in women. Future analyses on blood sex
hormone levels from this study population may aid in clarification of this point. In
addition, future studies on the association between CAG repeat number and body shape
should oversample individuals with extreme body shape phenotypes to clarifY this
relationship . Increased sample size may also aid in exposing other significant differences
between CAG repeat number and body shape, as well as if no differences exist.
Correlations between WHR and waist variables and body weight and BMI indicate
that higher body weights observed in older adults are primarily due to increases in
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abdominal adiposity.
Future analyses of data collected in this study will provide a wealth of information
on relationships among the AR gene CAG and GGN repeat regions in relationship to body
shape and blood sex hormone levels. Interactions with dietary intake and other
demographic data will also be assessed.

42
REFERENCES

I . Leading causes of death. National Center for Health Statistics. Center for Disease
Control. Hyattville, MD; (http://www.cdc.gov/nchs/).
2. Gordis L. Epidemiology. W.B. Saunders Company: Philadelphia, PA; 1996.
3. Willett W . Nutritional Epidemiology. Oxford University Press: New York, NY;
1990.
4. Caporaso N . Molecular Epidemiology: a brief overview. Educational Sessions and
Methods Workshops of the 89th Annual Meeting of the American Association for
Cancer Research, 1998.
5. Heiss CJ, Sanborn CF, Nicholas DL, Bonnick SL, Alford BB. Associations ofbody
fat distribution, circulating sex hormones, and body density in postmenopausal women .
J Clin Endocrinol Me tab 1995; 80: 1591 - 1696.
6. Goodman-Gruen D, Barrett-Conner E . Sex differences in measures of body fat and
body fat distributions in the elderly. Am J Epidemiol1996; 143: 898-906.
7. Vanltaille TB . Waist Circumference: A useful index in clinical care and health
promotion. Nut Rev 1998; 56(10): 300-313 .
8. Rimm EB, Stampfer MJ, Giovannuci E, Ascherio A, Spiegelman D, Colditz GA,
Willett W. Body size and fat distributions as predicators of coronary heart disease
among middle aged and older US men. Am J Epidemiol 1995; 141 : 1117-1127.
9. Sellers T A, Gapstur SM, Potter ID, Kushi LH, Bostick RM, Folsom AR. Association
of body fat distribution and family histories ofbreast and ovarian cancer with risk of
postmenopausal breast cancer. Am J Epidemiol 1993; 138: 799-803 .
10. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiologic data.
Am J Clin Nut 1997; 66(4S): 1044S-1 OSOS.
11 . Hegele RA, Brunt JH, Connelly PW. Genetic variation on chromosome 1 associated
with variation in body fat distribution in men. Circulation 1995; 92( 5): 1089-93.
12. Fugisawa T, Ikegami H, Kawaguchi Y, Ogihara T . Meta-analysis of the association of
TRP64Arg polymorphism ofbeta 3-adrenergic receptor gene with body mass index. J
Clin Endocrinol Metab 1998; 83(7): 2441-4.

43
13 . Hofbauer LC, Khosla S. Androgen effects on bone metabolism: recent progress and
controversies. EurJ Endocrinol 1999; 140(4): 271-86.
14. Irvine RA, Yu MC, Ross RK, Coetzee GA. The CAG and GGC rnicrosatellites of the
androgen receptor gene are in linkage disequilibrium in men with prostate cancer.
Cancer Res 1995; 55: 1937-40.
15 . Simental JA, Sar M, Lane MV, French FS,Wilson EM. Transcriptional activation and
nuclear targeting signals ofthe human androgen receptor. J Bioi Chem 1991; 266:
510-518 .
16. Chamberlain NC, Driver ED, Miesfeld RL. The length and location ofCAG
trinucleotide repeats in the androgen receptor N-terrninal domain affect transactivation
function. Nuc Acid Res 1994; 22: 3181 -3186.
17. Tilley WD, Marcelli M, Wilson JD, McPhaul MJ. Characterization and expression of
a eDNA encoding the human androgen receptor. Proc Nat/ Acad Sci 1989; 86: 327331..
18. Chang C, Kokontis J, Liao S. Structural analysis of complementary DNA and amino
acid sequences ofhuman and rat androgen receptors. Proc Nat/ Acad Sci 1988; 85:
7221-7215 .
19. Ross RK, Henderson BE. Do diet and androgens alter prostate cancer risk via a
common etiological pathway? J Nat/ Cancer Instit 1994; 86: 252-254.
20. Coetzee GA, Ross RK. Prostate cancer and the androgen receptor. J Nat/ Cancer
Instil 1994; 86: 872-873.
21 . Hardy DO, Scher Ill, Bogenreider R, Sabbatini P, Zhang ZF, Nanus DM, Catterall JF.
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of
onset. J Clin Endocrinol Metab 1996; 81 : 4400-4405 .
22. Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Brufsky A, Talcott J,
Hennekens CH, Kant off PW. The CAG repeat within the androgen receptor gene and
its relationship to prostate cancer. Proc Nat/ Acad Sci 1997; 94: 3320-3323 .
23 . Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, Blumenstein BA, Ostrander
EA. Polymorphic repeats in the androgen receptor gene: molecular markers of
prostate cancer risk. Cancer Res 1997; 57(6): 1194-8.

44
24. Schoenberg MP, Hakimi JM, Wang S, Bova S, Epstein n, Fischbeck KH, Isaacs WB,
Walsh PC, Barrack ER Microsatellite mutation (CAG 24-18) in the androgen
receptor gene in human prostate cancer. Biochem Biophys Res Comm 1994; 198: 8480.
25 . Alberts B, Bray D, Lewis J, RaffM, Roberts K, Watson J Molecular Biology of the
Cell. Third Edition. Garland Publishing: New York, NY; 1994.
26. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of
Hpaii and Hhal sites near the polymorphic CAG repeat in the human androgen
receptor gene correlates with X chromosome inactivation. Am J Hum Gen 1992; 51 :
1229-1 239.
27. Rebbeck TR, KantoffPW, Krithivas K, Neuhausen S, Blackwood MA, Godwin AK,
Daly MB, Narod SA, Garber JE, Lynch HT, Weber BL, Brown M. Modification of
BRCA !-associated breast cancer risk my polymorphic androgen-receptor CAG repeat.
AmJHum Gen 1999; 64(5): 1371 -7.
28 . Spurdle AB, Dite GS, Chen X, Mayne CJ, Southey MC, Batten LE, Chy H, Trute L,
McCredie 'MR. Giles GG, Armes J, Venter DJ, Hopper JL, Chenevix-Trench G.
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age
fortyyears . JNat/ Cancerlnstit 1999; 91(1 1): 961-6.
29. Wild RA Obesity, lipids, cardiovascular risk and androgen excess. Am J Med 1995;
98: 27S-32S.
30. Derman RJ. Effects of sex steroids on women' s health: implication of practitioners.
AmJMed 1995; 98: 137S- 143S.
3 1. Legro RS, Shahbahrami B, Lobo RA, Kovacs BW. Size polymorphisms ofthe
androgen receptor among female Hispanics and correlation with androgenic
characteristics. Obstet Gyneco/ 1994; 83: 701-706.
32. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular
atrophy oflate onset- a sex linked recessive trait. Neurology 1968; 18: 671-680.
33 . La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen
receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature
1991 ; 352: 77-79.
34. MacLean HE, Choi WT, Rekaris G, Warne GL, Zajac JD. Abnormal androgen
receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar
muscular atrophy). J Clin Endocrinol Metab 1995; 80(2): 508-16.

45
35 . Croft JB, Keenan NL, Sheridan DP, Wheeler FC, Speers MA. Waist to hip ratio in a
biracial population: Measurements, implication and cautions for using guidelines to
define high risk for cardiovascular disease. JAm Dietel Assoc 1995; 91: 60-64.
36. Oetting WS, Hanoko HY, Mentink MM, Paller AS, White JG, King RA. Molecular
analysis of an extended family with type 1A (tyrosinase-negative) oculo-cutaneous
albinism. J Invest Dermato/1991; 97: 15-19.
37. Stoll BA. Breast cancer: the obesity connection. Brit J Cancer 1994; 69: 799-801 .
38. Kirschner MA, Samojlik E, Drejka M, Szmal E, Schneider G, Ertel N. Androgenestrogen metabolism in women with upper body versus lower body obesity. J Clin
Endocrinol A1etab 1990; 70(2): 473-479.
39. Schapira DV, Kumar NB, Lynam GH. Obesity, body fat distribution, and sex
hormones in breast cancer patients. Cancer 1991; 67: 2215-2218 .

